p16 (CDKN2/MTS1) Gene Deletions are Rare in Prostatic Carcinomas in the United States and Japan
โ Scribed by Mangold, Kathy A.; Takahashi, Hiroyuki; Brandigi, Claus; Wada, Tetsuro; Wakui, Shin; Furusato, Masakuni; Boyd, Jeff; Chandler, Francis W.; Allsbrook, William C.
- Book ID
- 122491453
- Publisher
- Lippincott Williams and Wilkins
- Year
- 1997
- Tongue
- English
- Weight
- 538 KB
- Volume
- 157
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t
The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).